Cronos Group Revenue and Competitors
Estimated Revenue & Valuation
- Cronos Group's estimated annual revenue is currently $7M per year.
- Cronos Group received $65.0M in venture funding in January 2019.
- Cronos Group's estimated revenue per employee is $18,041
- Cronos Group's total funding is $1.8B.
Employee Data
- Cronos Group has 388 Employees.
- Cronos Group grew their employee count by 15% last year.
Cronos Group's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO at Cronos Group | Reveal Email/Phone |
2 | VP & Controller (Principal Accounting Officer) | Reveal Email/Phone |
3 | SVP, Corporate Affairs & Strategy | Reveal Email/Phone |
4 | VP Operations & Supply Chain | Reveal Email/Phone |
5 | VP Supply Chain | Reveal Email/Phone |
6 | Head Treasury | Reveal Email/Phone |
7 | VP Finance | Reveal Email/Phone |
8 | VP Technology and Partnerships | Reveal Email/Phone |
9 | VP, Global Head Tax | Reveal Email/Phone |
10 | Head Finance Transformation | Reveal Email/Phone |
Cronos Group Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $568.6M | 1116 | -17% | $4.5B | $3.5B |
#2 | $55.6M | 2784 | 28% | $2.1B | $8.2B |
#3 | $45.2M | 225 | -50% | N/A | N/A |
#4 | $563.6M | 633 | 2% | $48.6M | $3.3B |
#5 | $79.7M | 259 | 10% | $86.5M | N/A |
What Is Cronos Group?
Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across four continents. The Company operates two wholly-owned Canadian Licensed Producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations: Peace Naturals Project Inc. (Ontario), which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd. (British Columbia), which is based in the Okanagan Valley. The Company has multiple international production and distribution platforms: Cronos Israel and Cronos Australia. Through an exclusive distribution agreement, Cronos also has access to over 12,000 pharmacies in Germany as the Company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.
keywords:N/A
$1.8B
Total Funding
388
Number of Employees
$7M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cronos Group News
This was the stock's third consecutive day of losses. Cronos Group Inc. closed $6.36 short of its 52-week high ($9.42), which the company...
Cronos Group Inc. closed $6.30 short of its 52-week high ($9.42), which the company achieved on June 9th. The stock underperformed when compared...
Cronos Group Inc's score of 22 means that it ranks higher than 22% of stocks in the sector. In addition, its overall score of 26 ranks it higher...
Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using fermentation and proprietary methods to produce CBG without using the cannabis plant The SPINACH FEELZ™ platform’s latest product innovation, the Chill Bliss gummy, is a first-of-its kind CBG ...
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $102.1M | 389 | N/A | N/A |
#2 | $102.1M | 389 | 3% | N/A |
#3 | $141.4M | 390 | 3% | N/A |
#4 | $121M | 392 | 1% | $3M |
#5 | $69.9M | 393 | -22% | $190.6M |
Cronos Group Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-12-10 | $1800.0M | Undisclosed | Altria Group | Article |
| 2019-01-24 | $65.0M | Undisclosed | Canadian Imperial Bank of Commerce | Article |